<div id="readability-page-1"><div><p>InnoCare Pharma Limited reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 1,115.33 million compared to CNY 697.75 million a year ago. Net loss was CNY 64.41 million compared to CNY 275.41 million a year ago.</p><p>Basic loss per share from continuing operations was CNY 0.04 compared to CNY 0.16 a year ago. Diluted loss per share from continuing operations was CNY 0.04 compared to CNY 0.16 a year ago.</p></div></div>

诺诚健华-U

诺诚健华

<p>诺诚健华有限公司公布了截至 2025 年 9 月 30 日的九个月财报。该公司在这九个月内的销售额为 11.1533 亿元人民币，而去年同期为 6.9775 亿元人民币。净亏损为 6441 万元人民币，而去年同期为 2.7541 亿元人民币。持续经营业务的基本每股亏损为 0.04 元人民币，而去年同期为 0.16 元人民币。持续经营业务的摊薄每股亏损为 0.04 元人民币，而去年同期为 0.16 元人民币</p>

诺诚健华有限公司公布了截至2025年9月30日的九个月财务业绩